Presence of Genetic Variants Among Young Men With Severe COVID-19-Reference-Cited by-同舟云学术

Presence of Genetic Variants Among Young Men With Severe COVID-19

Published:2020-08-18 Issue:7 Volume:324 Page:663
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

van der Made Caspar I.¹²³⁴,Simons Annet¹,Schuurs-Hoeijmakers Janneke¹,van den Heuvel Guus⁵,Mantere Tuomo¹,Kersten Simone¹²³,van Deuren Rosanne C.¹²³,Steehouwer Marloes¹,van Reijmersdal Simon V.¹,Jaeger Martin²³,Hofste Tom¹,Astuti Galuh¹,Corominas Galbany Jordi¹,van der Schoot Vyne⁶,van der Hoeven Hans⁷,Hagmolen of ten Have Wanda⁵,Klijn Eva⁸,van den Meer Catrien⁹,Fiddelaers Jeroen¹⁰,de Mast Quirijn²³⁴,Bleeker-Rovers Chantal P.²⁴¹¹,Joosten Leo A. B.²³⁴,Yntema Helger G.¹¹²,Gilissen Christian¹³,Nelen Marcel¹,van der Meer Jos W. M.²³⁴,Brunner Han G.¹⁶¹²¹³,Netea Mihai G.²³⁴¹⁴,van de Veerdonk Frank L.²³⁴,Hoischen Alexander¹²³⁴

Affiliation:

1. Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands

2. Radboud University Medical Center Center for Infectious Diseases (RCI), Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands

3. Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

4. Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, the Netherlands

5. Pulmonology Department, Radboud University Medical Center, Nijmegen, the Netherlands

6. Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands

7. Department of Intensive Care, Radboud University Medical Center Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, the Netherlands

8. Department of Intensive Care, Erasmus Medical Center, Rotterdam, the Netherlands

9. Department of Intensive Care, Ziekenhuis Rivierenland, Tiel, the Netherlands

10. Department of Pulmonology, Admiraal de Ruyter Ziekenhuis, Goes, the Netherlands

11. Radboud Institute Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

12. Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands

13. GROW School of Oncology and developmental biology, and MHeNs School of Mental Health and Neuroscience, Maastricht University, the Netherlands

14. Immunology and Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2768926/jama_van_der_made_2020_pc_200003_1597433017.97129.pdf

Reference40 articles.

1. Airborne transmission of SARS-CoV-2: theoretical considerations and available evidence.;Klompas;JAMA,2020

2. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.;Richardson;JAMA,2020

3. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy.;Grasselli;JAMA,2020

4. Clinical characteristics of coronavirus disease 2019 in China.;Guan;N Engl J Med,2020

5. The trinity of COVID-19: immunity, inflammation and intervention.;Tay;Nat Rev Immunol,2020

Cited by 642 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stratified analyses refine association between TLR7 rare variants and severe COVID-19;Human Genetics and Genomics Advances;2024-10

2. Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables;Scientific Reports;2024-09-05

3. The Functions of SARS-CoV-2 Receptors in Diabetes-Related Severe COVID-19;International Journal of Molecular Sciences;2024-09-05

4. Efficacy of molnupiravir and interferon for the treatment of SARS‐CoV‐2 in golden Syrian hamster;Journal of Medical Virology;2024-08-29

5. Identification of biomarkers for COVID-19 associated secondary hemophagocytic lymphohistiocytosis;2024-08-15